Pharmacovigilance in Qatar: A survey of pharmacists;Pharmacovigilance au Qatar: Enquête auprès des pharmaciens

Eastern Mediterranean Health Journal

Volumn 19, Issue 11, 2013, Pages 930-935

  Wilbur, K ^a  

^a University of Qatar ^*  (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE SURVEY; HUMAN; JOB EXPERIENCE; KNOWLEDGE; MALE; NOMENCLATURE; PHARMACIST; PRODUCTIVITY; QATAR; QUESTIONNAIRE; TRAINING;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; FEMALE; HUMANS; MALE; PHARMACISTS; PHARMACOVIGILANCE; QATAR; QUESTIONNAIRES;

EID: 84890479490     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2013.19.11.930     Document Type: Article

References (15)

1. Belton KJ; The European Pharmacovigilance Research Group. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. European Journal of Clinical Pharmacology, 1997, 52:423-427.
2. Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharmacy World and Science, 2008, 30:556-562.
3. Bawazir SA. Attitude of community pharmacists in Saudi Arabia towards adverse drug reaction reporting. Saudi Pharmaceutical Journal, 2006, 14:75-83.
4. Al-Sultan MS, Bawazir SA. Adverse drug reaction reporting by hospital pharmacists in Saudi Arabia. Saudi Pharmaceutical Journal, 2009, 17:95-105.
5. Su C, Ji H, Su Y. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiology and Drug Safety, 2010, 19:217-222.
6. Nita Y, Batty KT, Plumridge RJ. Adverse drug reaction reporting: attitudes of Australian hospital pharmacists and doctors. Journal of Pharmacy Practice and Research, 2005, 35:9-14.
7. Wilbur K. Pharmacovigilance in Qatar hospitals. Pharmaceutical Medicine, 2012, 26:23-25.
8. Kheir N et al. Pharmacy education and practice in 13 Middle Eastern countries. American Journal of Pharmaceutical Education, 2009, 72:1-13.
9. World Health Organization. International drug monitoring the role of the hospital. A WHO report. Drug Intelligence and Clinical Pharmacy, 1970, 4:101-111.
10. Aronson JK. Medication errors: definitions and classification. British Journal of Clinical Pharmacology, 2009, 67:599-604.
11. Irujo M et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Safety, 2007, 30:1073-1082.
12. Elkalmi RM et al. A qualitative study exploring barriers and facilitators of reporting adverse drug reactions (ADRs) among community pharmacists in Malaysia. Journal of Pharmaceutical Health Services Research, 2011, 2:71-78.
13. Al-Sultan MS, Bawazir SA. Adverse drug reaction reporting by hospital pharmacists in Saudi Arabia. Saudi Pharmaceutical Journal, 2009, 17:95-105.
14. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Annals of Internal Medicine, 2004, 140:795-801.
15. Vallano A et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. British Journal of Clinical Pharmacology, 2005, 60:653-658.